Vildagliptin-13C5,15N structure
|
Common Name | Vildagliptin-13C5,15N | ||
---|---|---|---|---|
CAS Number | 1044741-01-6 | Molecular Weight | 309.36 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C1213C5H25N215NO2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Vildagliptin-13C5,15NVildagliptin-13C5,15N (LAF237-13C5,15N; NVP-LAF 237-13C5,15N) is a 13C- and 15N-labeled Vildagliptin (HY-14291). Vildagliptin (LAF237) is a potent, stable, selective dipeptidyl peptidase IV (DPP-IV) inhibitor with an IC50 of 3.5 nM in human Caco-2 cells. Vildagliptin possesses excellent oral bioavailability and potent antihyperglycemic activity[1][2]. |
Name | (2S)-1-[2-[(3-hydroxy-1-adamantyl)amino]acetyl]pyrrolidine-2-carbonitrile |
---|
Description | Vildagliptin-13C5,15N (LAF237-13C5,15N; NVP-LAF 237-13C5,15N) is a 13C- and 15N-labeled Vildagliptin (HY-14291). Vildagliptin (LAF237) is a potent, stable, selective dipeptidyl peptidase IV (DPP-IV) inhibitor with an IC50 of 3.5 nM in human Caco-2 cells. Vildagliptin possesses excellent oral bioavailability and potent antihyperglycemic activity[1][2]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C1213C5H25N215NO2 |
---|---|
Molecular Weight | 309.36 |
Exact Mass | 309.20800 |
PSA | 76.36000 |
LogP | 1.50308 |